#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Glomerulonephritis membranoproliferative Hyperinsulinaemic hypoglycaemia Fibrosarcoma Arterial disorder Dupuytren's contracture Fibrodysplasia ossificans progressiva Infantile apnoea Prostate cancer Heritable pulmonary arterial hypertension Adrenocortical carcinoma Hidradenitis Brain stem glioma Waldenstrom's macroglobulinaemia refractory Spinal muscular atrophy More trials…

    Learn about Rare Diseases

    Osteosarcoma – Diagnostics Propionic acidaemia – Basic Information Chordoma – Trials in Disease Pelizaeus-Merzbacher disease – Basic Information Crigler-Najjar syndrome – Diagnostics Acquired haemophilia – Trials in Disease Advanced systemic mastocytosis – Basic Information Medulloblastoma recurrent – Life with Disease Inclusion body myositis – Life with Disease Shprintzen-Goldberg syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pevonedistat Defactinib SRSD107 Dextran 70 Psilocybine Regn5668 GSK5784283 Rotigotine Fostemsavir Trometamol Amikacin Sar442970 Melphalan Ttx-030 Dabigatran Etexilate Ofatumumab Xp-Dc+Tl+Klh Buclizine Hydrochloride Benzalkonium Chloride Dulaglutide Tigecycline More therapies…

    Learn about Your Condition

    Hereditary optic atrophy Ventricular fibrillation Deafness traumatic Coma Noonan syndrome Endometrial stromal sarcoma Post procedural swelling Femoral neck fracture Suicidal ideation Depression Mite allergy Colorectal adenoma Sepsis Fallopian tube cancer Invasive breast carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

  • Long‑Term Safety Follow‑up of Ornithine Transcarbamylase Deficiency Patients Treated with ECUR‑506D and ECUR‑506A

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ornithine transcarbamoylase deficiency
    Investigated Drugs:
    • Adeno-Associated Virus Serotype Rh79 Containing The Human Otc Gene
    France Spain

  • Study on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Factor IX deficiency
    • Factor VIII deficiency
    • Haemophilia A without inhibitors
    Investigated Drugs:
    • Concizumab
    Bulgaria France Greece Italy Lithuania Norway +4

  • A Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ro7589655
    • Simoctocog Alfa
    Austria Denmark France Germany Hungary Italy +3

  • Evaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Emicizumab
    • Ro7589655
    Austria Belgium Denmark France Germany Hungary +5

  • BMN 333 Versus Vosoritide in Children With Achondroplasia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Vosoritide
    Italy Poland Romania

  • A study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis

    Recruiting

    2 1
    Investigated Drugs:
    • VAMIFEPORT TRIHYDROCHLORIDE
    Austria Belgium Czechia France Germany Ireland +5
1 2 3 … 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!